Navigation Links
Myelodysplastic Syndrome Linked to Abnormal Stem Cells
Date:7/5/2012

THURSDAY, July 5 (HealthDay News) -- As researchers suspected, abnormal bone marrow stem cells trigger the development of myelodysplastic syndromes, serious blood diseases that affect the bone marrow and can progress to leukemia, according to a new study.

"Good Morning America" host Robin Roberts recently disclosed that she had developed myelodysplastic syndrome, or MDS, as a rare complication of her breast cancer treatment. The syndrome is diagnosed in about 10,000 to 15,000 people in the United States each year, mostly in men and in those over age 60.

The new findings, published in the July 2 online edition of Blood, could lead to improved treatments for myelodysplastic syndrome and cancers related to the syndrome, researchers from the Albert Einstein College of Medicine of Yeshiva University, in New York City, suggested in an Einstein news release.

"Researchers have suspected that [myelodysplastic syndrome] is a 'stem cell disease,' and now we finally have proof," said the study's co-senior author Amit Verma, an associate professor of medicine and of developmental and molecular biology at Einstein and attending physician in oncology at Montefiore Einstein Center for Cancer Care.

"Equally important, we found that even after [myelodysplastic syndrome] standard treatment, abnormal stem cells persist in the bone marrow. So, although the patient may be in remission, those stem cells don't die and the disease will inevitably return. Based on our findings, it's clear that we need to wipe out the abnormal stem cells in order to improve cure rates," Verma explained in the news release.

For the study, the researchers analyzed bone marrow stem cells and the progenitor cells, or cells formed by stem cells, of 16 patients with various types of myelodysplastic syndrome. They compared these cells to those of 17 people who did not have the syndrome.

The investigators found widespread genetic and epigenetic (related to environmental factors) variations in the stem and progenitor cells taken from myelodysplastic syndrome patients. The abnormalities were more obvious in those with more serious forms of the disease, the researchers noted.

"Our study offers new hope that [myelodysplastic syndromes] can be more effectively treated, with therapies that specifically target genes that are deregulated in early stem and progenitor cells," the study's co-senior author Dr. Ulrich Steidl, an assistant professor of cell biology and of medicine at Einstein, said in the news release. "In addition, our findings could help to detect minimal residual disease in patients in remission, allowing for more individualized treatment strategies that permanently eradicate the disease."

More information

The U.S. National Library of Medicine has more about myelodysplastic syndromes.

-- Mary Elizabeth Dallas

SOURCE: Albert Einstein College of Medicine, news release, July 2, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Myelodysplastic syndrome treated with deferasirox shows beneficial iron reduction, Moffitt says
2. Normal triglyceride levels in people of African descent may hinder diagnosis of metabolic syndrome
3. Study: Women not getting enough exercise; at risk of developing metabolic syndrome
4. Cedars-Sinai physician definitively links irritable bowel syndrome and bacteria in gut
5. Broken heart syndrome protects the heart from adrenaline overload
6. Antibiotics Linked to Retinal Detachment Risk
7. Pesticides May Be Linked to Slightly Smaller Babies, Shorter Pregnancies
8. Pharmacy Robots Linked to Bacterial Contamination of Drugs
9. 2 genetic deletions in human genome linked to the development of aggressive prostate cancer
10. Dental X-Rays May Be Linked to Benign Brain Tumors
11. In Mice, Drug Reverses Symptoms of Condition Linked to Autism
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Myelodysplastic Syndrome Linked to Abnormal Stem Cells 
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a ... can give their videos a whole new perspective by using the title layers ... Film Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Austin residents ... the American College of Mohs Surgery and to Dr. Russell Peckham for medical and ... highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, ... and the Road To Recovery® program to drive cancer patients to and from their ... to ensure the highest quality of life and ongoing independence. Getting to and ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... a startling report released today, National Safety Council research ... proven plan to eliminate prescription opioid overdoses. Prescription Nation ... tackling the worst drug crisis in recorded U.S. history, assigned a ... , New Mexico , Tennessee ... failing states, three – Michigan , ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... VIEW, Calif. , June 23, 2016 ... a.m. CST on Thursday, July 7, 2016 , , , ... kayla.belcher@frost.com ) , , , , EXPERT PANELISTS:  , ... Nitin Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa ... The global pharmaceutical industry is witnessing an ...
Breaking Medicine Technology: